Search Results

Gerard (Jerry) Greco, Ph.D.

Gerard (Jerry) Greco, Ph.D., is senior vice president, chief quality officer. Greco joined Baxter in 2023 from Takeda Pharmaceuticals, where he most recently served as the global quality officer, leading all quality and quality compliance for the company. During his 35-plus years in the healthcare industry, he has served in quality roles of increasing responsibility at Teva Pharmaceuticals, Pfizer, Wyeth Pharmaceuticals and Johnson & Johnson.

Olimel Portfolio

The Olimel portfolio consists of eight unique olive oil-based parenteral (intravenous) nutrition formulations designed to match the personalized protein and energy needs of patients.

Doxil (doxorubicin HCl liposome injection) for Hospital Care

Doxil  (doxorubicin HCl liposome injection) is indicated for treatment of ovarian cancer, acquired immune deficiency syndrome (AIDS)-related Kaposi’s Sarcoma, and multiple myeloma.

Tobi Karchmer, M.D., M.S.

Tobi Karchmer, M.D., M.S., is senior vice president and chief medical and scientific officer. Prior to her appointment to chief medical officer in 2021, Karchmer served as vice president, Worldwide Medical, which consists of Baxter's Global and Regional Medical Affairs teams, Clinical Research team and Strategy and Delivery team.

Piero Novello

Piero Novello is senior vice president and president, Growth & Emerging Markets.

Nancy M. Schlichting

Nancy M. Schlichting has served as a director of Baxter since December 2021.

Joel Grade

Joel Grade is executive vice president and chief financial officer. Grade joined Baxter in 2023 following a 25-year career with Sysco, the world's global foodservice leader. He most recently served as Sysco's executive vice president, corporate development. His previous roles included executive vice president and chief financial officer, senior vice president of finance and chief accounting officer, and senior vice president of foodservice operations. 

Patricia B. Morrison

Patricia B. Morrison has served as a director of Baxter since 2019.